Advertisement
Screener

HCW Biologics Inc. (HCWB) Form D

HCW Biologics Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2026-06-08: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2026-05-21; Total offering amount $4,000,000.
  • 2024-12-05: Federal exemption Rule 506(b); Types of securities offered OptionToAcquire; Date of first sale 2024-11-20; Total offering amount $6,918,254.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2026-06-08Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2026-05-21$4,000,000$4,000,000$07
2024-12-05Rule 506(b)OptionToAcquire2024-11-20$6,918,254$6,918,254$01

Similar stocks

Stock NameCountryMarket CapPE Ratio
REVELATION BIOSCIENCES, INC. (REVB)United States$0.004B
Onconetix, Inc. (ONCO)United States$0.004B
Aptevo Therapeutics Inc. (APVO)United States$0.003B
60 DEGREES PHARMACEUTICALS, INC. (SXTP)United States$0.004B-0.59
Sunshine Biopharma Inc. (SBFM)$0.003B
Lakewood-Amedex Biotherapeutics Inc. (LABT)United States$0.004B
Cadrenal Therapeutics, Inc. (CVKD)United States$0.004B-0.90
Alaunos Therapeutics, Inc. (TCRT)United States$0.003B-1.44
Genprex, Inc. (GNPX)United States$0.003B-0.02
Silo Pharma, Inc. (SILO)United States$0.003B-1.57